Striking Differences in NF1 Mice Treated with MEKi Drug (IMAGE)

Michigan Medicine - University of Michigan

Striking Differences in NF1 Mice Treated with MEKi Drug

Caption

This image is a striking demonstration of the impact of treating mice with neurofibromatosis 1 with a type of cancer drug known as an MEK inhibitor. On the left are a normal mouse and a mouse with the NF1 gene mutation, both of which received a placebo. On the right, a normal mouse and a mouse with the NF1 mutation, after receiving the MEKi drug starting shortly after birth.

Credit

Zhu lab, University of Michigan Medical School

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.